Showing results (1641-1650 of 2,264) with videos related to

Sort By:
Pageof 227
Circulation|April 1, 1995
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I InvestigatorsR J Simes, E J Topol, D R Holmes, et al.
Molecular Microbiology|September 1, 2006
Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2Ann R Holmes, Sarah Tsao, Soo-Wee Ong, et al.
Journal of the American College of Cardiology|October 13, 1998
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventionsR D Anderson, E M Ohman, D R Holmes, et al.
Mayo Clinic Proceedings|July 1, 1985
Percutaneous transluminal coronary angioplasty, alone or in combination with streptokinase therapy, during acute myocardial infarctionD R Holmes, H C Smith, R E Vlietstra, et al.
American Heart Journal|August 15, 1998
Intravenous adenosine and lidocaine in patients with acute myocardial infarctionK N Garratt, D R Holmes, V Molina-Viamonte, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 10, 2021
Ten-Year All-Cause Mortality Following Staged Percutaneous Revascularization in Patients With Complex Coronary Artery DiseaseHideyuki Kawashima, Masafumi Ono, Hironori Hara, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 21, 2010
Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two yearsFriedrich W Mohr, Ardawan J Rastan, Patrick W Serruys, et al.
American Heart Journal|December 15, 2010
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesionsLaura Mauri, Dean J Kereiakes, Sharon-Lise T Normand, et al.
JACC. Cardiovascular Interventions|June 15, 2020
Reoperation After Transcatheter Aortic Valve Replacement: An Analysis of the Society of Thoracic Surgeons DatabaseOliver K Jawitz, Brian C Gulack, Maria V Grau-Sepulveda, et al.
European Heart Journal|June 24, 2011
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trialArie Pieter Kappetein, Ted E Feldman, Michael J Mack, et al.
Pageof 227